Bio Essence Corporation BIOE
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 210.53% | 179.30% | 168.47% | -- | -- |
| Total Depreciation and Amortization | 17,216.67% | -50.00% | -66.67% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.14% | -97.63% | -96.23% | -- | -- |
| Change in Net Operating Assets | -155.67% | -115.18% | -22.87% | -- | -- |
| Cash from Operations | 16.69% | 53.87% | 151.61% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84,700.00% | -- | -- | -- | -- |
| Total Debt Issued | 42.12% | 448.74% | -- | -- | -- |
| Total Debt Repaid | -51.22% | -163.85% | -281.70% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.31% | -49.17% | -152.39% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.22% | 18,200.00% | -216.67% | -- | -- |